Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 3
1947 2
1949 2
1972 2
1973 5
1974 1
1975 6
1976 2
1977 3
1978 2
1982 2
1984 2
1985 2
1986 1
1988 2
1989 1
1990 1
1991 7
1992 4
1993 6
1994 5
1995 6
1996 5
1997 2
1998 3
1999 3
2000 4
2001 3
2002 3
2003 4
2004 9
2005 8
2006 9
2007 6
2008 4
2009 4
2010 7
2011 5
2012 4
2013 4
2014 9
2015 11
2016 9
2017 11
2018 13
2019 8
2020 10
2021 9
2022 6
2023 6
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

234 results

Results by year

Filters applied: . Clear all
Page 1
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients.
Wilson MR, Eyre TA, Kirkwood AA, Wong Doo N, Soussain C, Choquet S, Martinez-Calle N, Preston G, Ahearne M, Schorb E, Moles-Moreau MP, Ku M, Rusconi C, Khwaja J, Narkhede M, Lewis KL, Calimeri T, Durot E, Renaud L, Øvlisen AK, McIlroy G, Ebsworth TJ, Elliot J, Santarsieri A, Ricard L, Shah N, Liu Q, Zayac AS, Vassallo F, Lebras L, Roulin L, Lombion N, Manos K, Fernandez R, Hamad N, Lopez-Garcia A, O'Mahony D, Gounder P, Forgeard N, Lees C, Agbetiafa K, Strüßmann T, Htut TW, Clavert A, Scott H, Guidetti A, Barlow BR, Tchernonog E, Smith J, Miall F, Fox CP, Cheah CY, El Galaly TC, Ferreri AJM, Cwynarski K, McKay P. Wilson MR, et al. Among authors: rusconi c. Blood. 2022 Apr 21;139(16):2499-2511. doi: 10.1182/blood.2021014506. Blood. 2022. PMID: 34995350 Free article.
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study.
Dreyling M, Jurczak W, Jerkeman M, Silva RS, Rusconi C, Trneny M, Offner F, Caballero D, Joao C, Witzens-Harig M, Hess G, Bence-Bruckler I, Cho SG, Bothos J, Goldberg JD, Enny C, Traina S, Balasubramanian S, Bandyopadhyay N, Sun S, Vermeulen J, Rizo A, Rule S. Dreyling M, et al. Among authors: rusconi c. Lancet. 2016 Feb 20;387(10020):770-8. doi: 10.1016/S0140-6736(15)00667-4. Epub 2015 Dec 7. Lancet. 2016. PMID: 26673811 Clinical Trial.
The potential of aptamers as anticoagulants.
Nimjee SM, Rusconi CP, Harrington RA, Sullenger BA. Nimjee SM, et al. Among authors: rusconi cp. Trends Cardiovasc Med. 2005 Jan;15(1):41-5. doi: 10.1016/j.tcm.2005.01.002. Trends Cardiovasc Med. 2005. PMID: 15795162 Review.
To PEGylate or Not To PEGylate Therapeutics?
Maier KE, Rusconi CP, Levy M. Maier KE, et al. Among authors: rusconi cp. Cell Chem Biol. 2019 May 16;26(5):615-616. doi: 10.1016/j.chembiol.2019.04.014. Cell Chem Biol. 2019. PMID: 31100258 Free article.
Putting the brain into mantle cell lymphoma.
Rusconi C, Visco C. Rusconi C, et al. Leuk Lymphoma. 2023 Feb;64(2):259-260. doi: 10.1080/10428194.2022.2163171. Epub 2023 Jan 2. Leuk Lymphoma. 2023. PMID: 36591725 No abstract available.
Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse.
Rusconi C, Cheah CY, Eyre TA, Tucker D, Klener P, Giné E, Crucitti L, Muzi C, Iadecola S, Infante G, Bernard S, Auer RL, Pagani C, Duglosz-Danecka M, Mocikova H, van Meerten T, Cencini E, Marin-Niebla A, Williams ME, Angelillo P, Nicoli P, Arcari A, Morello L, Mannina D, Vitagliano O, Sartori R, Chiappella A, Sciarra R, Stefani PM, Dreyling M, Seymour JF, Visco C. Rusconi C, et al. Blood. 2022 Oct 27;140(17):1907-1916. doi: 10.1182/blood.2022015560. Blood. 2022. PMID: 35789260 Free article.
Factor IXa inhibitors as novel anticoagulants.
Howard EL, Becker KC, Rusconi CP, Becker RC. Howard EL, et al. Among authors: rusconi cp. Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):722-7. doi: 10.1161/01.ATV.0000259363.91070.f1. Epub 2007 Feb 1. Arterioscler Thromb Vasc Biol. 2007. PMID: 17272750 Review.
Aptamers: an emerging class of therapeutics.
Nimjee SM, Rusconi CP, Sullenger BA. Nimjee SM, et al. Among authors: rusconi cp. Annu Rev Med. 2005;56:555-83. doi: 10.1146/annurev.med.56.062904.144915. Annu Rev Med. 2005. PMID: 15660527 Review.
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Gotti M, Sciarra R, Pulsoni A, Merli F, Luminari S, Zerbi C, Trentin L, Re A, Rusconi C, Viviani S, Rossi A, Cocito F, Botto B, Meli E, Pinto A, Dogliotti I, Gini G, Puccini B, Ricci F, Nassi L, Fabbri A, Liberati AM, Merli M, Filippi AR, Bonfichi M, Zoboli V, Tartaglia G, Annechini G, D'Elia GM, Del Giudice I, Alvarez I, Visentin A, Pravato S, Dalceggio D, Pagani C, Ferrari S, Cristinelli C, Lazic T, Ferretti VV, Ricardi U, Arcaini L. Gotti M, et al. Among authors: rusconi c. Hemasphere. 2023 Apr 4;7(4):e837. doi: 10.1097/HS9.0000000000000837. eCollection 2023 Apr. Hemasphere. 2023. PMID: 37034003 Free PMC article.
234 results